Ads
related to: new fda approved hiv drugs- Helpful Resources
Learn About An HIV Treatment
And Discover More About Dosing.
- Treatment Costs & Savings
See If You Are Eligible For Savings
Or Assistance Programs.
- HIV Treatment Injectable
Learn About A Treatment Option
And Find More Info Online Today.
- Helpful Patient Tools
Find Information For Patients Here.
Visit The Official Patient Website.
- Long-Acting HIV Treatment
Injections Just Every Other Month
With A Flexible Treatment Window.
- Get Treatment Resources
See Tools Specifically For Patients
About Dosing, Savings And More.
- Helpful Resources
Search results
Results From The WOW.Com Content Network
Antiretroviral drugs are used to manage HIV/AIDS. Multiple antiretroviral drugs are often combined into a single pill in order to reduce pill burden. Some of these combinations are complete single-tablet regimens; the others must be combined with additional pills to make a treatment regimen.
Lenacapavir was approved for medical treatment in the European Union in August 2022, [10] [12] in Canada in November 2022, [5] [6] and in the United States in December 2022. [9] [11] [13] [14] It is the first of a class of drugs called capsid inhibitors to be approved by the US Food and Drug Administration (FDA) for treating HIV/AIDS. [11] [15]
Fostemsavir is a human immunodeficiency virus type 1 (HIV-1) gp120-directed attachment inhibitor. [10] It was approved for medical use in the United States in July 2020, [7] [8] [10] and in the European Union in February 2021. [5] The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication. [11]
U.S. regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace the daily pills now used to control infection with the AIDS virus. Thursday’s approval of ...
(Reuters) - The U.S. Food and Drug Administration (FDA) on Thursday approved Gilead Sciences Inc's Sunlenca therapy for HIV infections, paving the way for a drug that requires less frequent dosing ...
The FDA has approved ViiV Healthcare's Apretude (cabotegravir extended-release injectable suspension) for use in adults and adolescents weighing at least 35 kilograms (77 pounds) for pre-exposure ...
Ads
related to: new fda approved hiv drugs